Here are five key points from the presentation:
1. Mr. Ishrak feels in the future healthcare will be an “economic driver, and not a cost driver,” according to the report. He challenged device companies to collect and apply data on economic value in the future.
2. There is currently a lack of accountability on the device company’s part because technology is paid for even if the procedure needs a reoperation; when reoperations occur, the system pays for the new device. He sees payment more depending on outcomes in the future.
3. Without change, Mr. Ishrak sees lawmakers taking drastic measures to reduce spending and cut costs at a rate that will be prohibitive for future innovation. He advised the industry to begin considering more accountability for value-based care.
4. In the future, healthcare will prize keeping individuals healthy and in the workforce longer.
5. Value-based outcomes will require more collaboration in the future.
More articles on orthopedic devices:
Zimmer Biomet, K2M, Medicrea & more: 6 device company key notes
Invibio invests resources to lower healthcare costs: 5 things to know
40 orthopedic devices receive FDA 510(k) clearance in October
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
